Patents by Inventor Thomas A. Delfino

Thomas A. Delfino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11958910
    Abstract: Provided herein are bispecific antigen-binding molecules that bind HER2 and methods of use thereof. The bispecific antigen-binding molecules comprise a first and a second antigen-binding domain, wherein the first and second antigen-binding domains bind to two different (preferably non-overlapping) epitopes of the extracellular domain of human HER2. The bispecific antigen-binding molecules cluster on the surface of HER2 IHC2+ and IHC3+ cells, and are internalized into the cellular lysosomes. Also included are antibody-drug conjugates (ADCs) comprising the antibodies or bispecific antigen-binding molecules provided herein linked to a cytotoxic agent, radionuclide, or other moiety, as well as methods of treating cancer in a subject by administering to the subject a bispecific antigen-binding molecule or an ADC thereof.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: April 16, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Julian Andreev, Andres Perez Bay, Christopher Daly, Frank Delfino, Amy Han, Thomas Nittoli, William Olson, Gavin Thurston
  • Patent number: 6150157
    Abstract: The invention provides methods and microbial cultures for the bioremediation of organic halide contaminated groundwater contaminated with organic halides, such as di- and trichloroethene. The methods involve adding, in situ to organic halide-contaminated groundwater a carbohydrate and one or more reductive dehalogenation factors, usually in the form of a nutrient extract, both in amounts sufficient to permit in situ reductive dehalogenation of the organic halide by a microbial population. The microbial population may be endogenous to the ground water or added exogenously. The nutrient-enriched ground water is then maintained in situ under reducing conditions to reductively dehalogenate the contaminating organic halide. Enriched bioremediation cultures are produced by adding to organic halide contaminated groundwater which comprises an endogenous microbial population capable of reductive dehalogenation of the organic halide a carbohydrate and frequently, one or more reductive dehalogenation factors.
    Type: Grant
    Filed: September 23, 1994
    Date of Patent: November 21, 2000
    Assignees: The Regents of the University of California, Geomatrix Consultants
    Inventors: Jay D. Keasling, Douglas G. Bolesch, Thomas A. Delfino